## **Core Concept**
The question tests the understanding of coagulation disorders related to liver disease and vitamin K's role in coagulation. Liver disease can affect coagulation factor production, and vitamin K is crucial for the gamma-carboxylation and activation of coagulation factors II, VII, IX, and X.

## **Why the Correct Answer is Right**
The normalization of prothrombin time (PT) after vitamin K injection indicates that the liver is capable of producing coagulation factors but lacks sufficient vitamin K for their activation. Vitamin K is essential for the post-translational modification (gamma-carboxylation) of vitamin K-dependent clotting factors. This scenario is characteristic of **vitamin K deficiency** or **early liver disease** where synthetic function is partially preserved.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, conditions like warfarin overdose or vitamin K deficiency would show similar responses.
- **Option B:** This option is also not provided, but conditions with severe liver dysfunction might not normalize with vitamin K alone if there's significant hepatocellular damage impairing factor production.
- **Option C:** If liver disease were severe, the liver might not produce enough clotting factors even with vitamin K, and PT might not normalize.
- **Option D:** Without the specific details of options A through D, the focus remains on understanding that vitamin K responsiveness indicates a problem with vitamin K-dependent factor activation rather than severe liver synthetic dysfunction.

## **Clinical Pearl / High-Yield Fact**
A key clinical point is that vitamin K can correct coagulopathy due to vitamin K deficiency or early liver disease but not in cases of severe liver failure where the liver's synthetic function is compromised. A classic scenario where this concept is tested is in differentiating between liver disease and vitamin K deficiency as causes of coagulopathy.

## **Correct Answer:** .